Prostate Cancer Crisis: Imaging is the Solution Faina Shtern, MD President, AdMeTech Foundation.

Slides:



Advertisements
Similar presentations
Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.
Advertisements

Implementing NICE guidance
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
The Challenge of Prostate Cancer Genitourinary Cancer Center at M. D. Anderson PERSONALIZED MEDICINE.
Screening for Prostate Cancer: Sharing the Decision 7/1/03.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
Pancreas Cancer Nimisha K. Parekh, MD, MPH
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Screening for Lung Cancer Jess Dalehite, M.D. Southwest Medical Imaging Midland Memorial Hospital.
A PRACTICAL GUIDE TO PSA SCREENING Kendall Itoku, MD St. Louis Urological Surgeons.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Clinical Utility of Combidex in Various Cancers
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Prostate Cancer: Education & Outreach
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Prostate Cancer Screening 2012 Paul L. Crispen, MD Department of Surgery University of Kentucky.
Presentation at WHRHS Alex Hohmann February 21-22, 2012
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Lecture Fourteen Biomedical Engineering for Global Health.
Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.
A Summary Of Key Findings From A National Survey Of Voters. #07160.
Prostate Screening in 2009: New Findings and New Questions Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer.
Prostate Cancer James B. Benton,M.D.. Prostate Cancer Significant of the clinical problem Early detection/screening Prevention/Management.
A/Prof Brian Cox Cancer Epidemiologist Dunedin. Research Associate Professor Brian Cox Hugh Adam Cancer Epidemiology Unit Department of Preventive and.
J. Jacques Carter, MD, MPH Assistant Professor of Medicine Department of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
Prostate Cancer Coalition of North Carolina Prostate Cancer / Breast Cancer Brother / Sister Diseases Your Name PCCNC Women’s Programs Your.
Speaker: Thomas A. Farrington, President and Founder, PHEN Remarks: Mark Kennedy, MBA, Senior Consultant, PHEN Why Knowledge is the Best Defense Against.
Genomic Health, Inc. Yuko Soneoka, Ph.D., J.D. Senior Corporate Counsel, IP Director of Intellectual Property January 31, 2013.
Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
The PSA Conundrum: Test or Die Patient Imperatives in the face of professional controversy Virgil Simons Founder & President The Prostate Net, Inc.®
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
A Clinical Profile of Male Health in the Bahamas “Real Men Die from Prostate Cancer” A Clinical Profile of Male Health in the Bahamas “Real Men Die from.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
Slainte an Chlar Health Education Day Cancer 20 th Feb 2010.
Prostate Cancer Management: A Guide for Patients and Caregivers
Module 3: Alzheimer’s Disease – What is the Role of Public Health? A Public Health Approach to Alzheimer’s and Other Dementias.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
PSA - Prostate Specific Antigen Bill Graden, M.D. BYU Student Health Center.
MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences.
Understanding Prostate Myths
Prostate cancer -what is important and what is new - Anette Hylen Ranhoff, MD PhD Ullevaal University Hospital Oslo Norway.
South West Public Health Observatory South West Regional Public Health Group Prostate cancer in England and the South West Sean McPhail 1, Paul Eves 1,
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
From EBM to SDM: Michel Labrecque MD PhD Michel Cauchon MD Department of Family and Emergency Medicine Université Laval Teaching how to apply evidence.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Breast Cancer in Young Women by Kim Wooden 1. Facts While the majority of women who develop breast cancer are postmenopausal, younger women are more likely.
The Elliott Breast Center * Baton Rouge, LA *
BREAST SELF- AWARENESS FOR OUR COMMUNITY Updated 3/2015.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
From EBM to SDM: Michel Labrecque MD PhD Michel Cauchon MD Department of Family and Emergency Medicine Université Laval Teaching how to apply evidence.
Screening for Prostate Cancer
Start the Conversation
Your Symptoms Matter – Prostate Cancer
2017 USPSTF Draft Recommendations for Prostate Cancer Screening
Cancer screening PROF .MAZIN AL-HAWAZ.
BME 301 Lecture Fourteen.
CONVERSATIONS ON PROSTATE CANCER
Shared Decision-Making
Active Surveillance for Low Risk Prostate Cancer
Prostate Cancer Update
2008 Behavioral Health Symposium
Empowering Members to Know Your Health & Own Your Health.
Presentation transcript:

Prostate Cancer Crisis: Imaging is the Solution Faina Shtern, MD President, AdMeTech Foundation

Prostate Cancer Crisis: Imaging is the Solution AdMeTech Foundation’s Mission: To End the Era of Blind Prostate Cancer Care: To Create a Future of Image-Guided, Minimally-Invasive Diagnosis & Treatment

Courtesy of: Thomas M. Wheeler, MD, Baylor College of Medicine

Prostate Cancer Crisis Prostate Cancer Epidemic “Blind” Diagnosis & Treatment Patient Care Crisis Socioeconomic Problem

Prostate Cancer Epidemic Most common major cancer: –1 in 6 men is diagnosed –A new case – every 2.5 minutes –A man dies of prostate cancer every 18 minutes In 2007:  30,000 men died  70,000 had treatment failures  230,000 new cases  1.5 million men had biopses

Prostate Cancer Epidemic & African American Men Greater risk (by 60%) Younger Men More Virulent & Lethal Disease Higher Mortality (>100%)

Imaging Technologies & Transformation of Prostate Cancer Care “If prostate cancer is caught at a time when it is confined to the prostate, generally it can be cured by radiotherapy and surgery” Professor Alan Horwich Royal Marsden Hospital, UK

Unnecessary Biopsies: Patient Care Crisis & Socioeconomic Impact  230,000 new cases  1.5 Million men have biopsies  1 Million men per year have unnecessary biopsies with related fears, trauma and costs  Costs for Healthcare:  Over $2 Billion per year

Unnecessary Biopsies: Patient Care Crisis & Socioeconomic Impact –20 million men who had biopsy –2 Million men live with prostate cancer –18 million men had unnecessary biopsies: Cost to Healthcare: $36 billion

Potential Cost Savings with Imaging Per Year  Cost of Unnecessary Biopsies:  $2.00 billion  Potential Cost of Imaging for Additional Screening and Diagnostic Procedures:  $600 million  Savings with Improved Imaging:  $1.4 billion (assuming cancer yield of only 25%)

Current Diagnosis and Treatment is Blind There are no accurate, affordable and accessible imaging and other diagnostic tools to guide: Early Detection Biopsy Treatment

Experimental MRI Shows Large 2 cm Mass Missed with Biopsies

Experimental MRI- Guided Biopsy Large 2 cm Tumor: Aggressive, virulent prostate cancer (Gleason Score: 8 & 9)

CT Imaging Shows Multiple Metastases

Rising PSA Multiple negative biopsies Experimental MRI - demonstrated tumor –Image-guided Biopsy showed virulent cancer –Metastases to lymph nodes Treated with chemotherapy & radiation Case Study: 53 Year Old Man with Negative Standard Biopsies for 5 years

Blind Prostate Cancer Treatment: Complications 50 – 80% of impotence 50-60% of incontinence

Mitchell Schnall, MD, PHD University of Pennsylvania Pioneer of Prostate-Dedicated MRI “What was the most devastating experience for my father… and what kept him embarrassed, ashamed and isolated from our family was his inability to control his bowels”

Treatment Failures: Prostate Cancer Crisis Efforts to Reduce Treatment Failures should be a clinical and public health priority

Barry Bostwick: Leading Man of Prostate Cancer Barry’s Diagnosis – at the age of 52 Barry Selected Radical Surgery –Diapers for Quite a While –Challenges with Intimacy –Shots and Viagra

Barry Bostwick: Leading Man of Prostate Cancer Barry’s Father - Diagnosis at the age of 81 Barry’s Father Selected Active Surveillance –No related problems or surgical complications

Barry Bostwick: Leading Man of Prostate Cancer “Was surgery really necessary?”

Prostate Cancer Care: Fundamental Dilemma To Treat or Not to Treat?

Socioeconomic Impact 2 million men live with prostate cancer 18 million have had unnecessary biopsies: –($36 billion) Treatment costs $8 billion per year –at least $2 billion is unnecessary Lost Lives Lost Quality of Life

Framing the Need for Prostate Imaging: Patrick Walsh, MD, Johns Hopkins Pioneer of Radical Surgery “The most critical pieces of information…are the precise location and extent of cancer within the prostate. I can’t think of anything more important. Right now, there is no proven method… we need that desparately. ”

Prostate Cancer Crisis: The Solution is Imaging Potential Annual Reduction of Health Care Costs with Imaging: –$1.4 billion (unnecessary biopsies) –$1.6 billion (unnecessary treatment) –$2 billion (minimally-invasive treatment) –Total Reduction: $5 billion

“…but you have to demand it to get it." “”